|
 |
|
|
 |
 |
 |
 |
 |  |
 |
 |
 |
 |
 |
| Dr Pieter Telleman Director, MIC-Department of Micro- and Nanotechnology Candidacy Statement My initial contact to MANCEF was through Dr. Kees Eijkel, President of the Executive Board of Directors of MANCEF. MANCEF's attention to commercialization of miniaturization technologies is one that is of great interest to my organisation. My close collegue Prof. Dr. Aric Menon participated in the COMS05 meeting to asses the possibility for MIC to get more closely involved with MANCEF. The vision of my organization is to ensure the establishment of a micro- and nanotechnology industry in Denmark. Our mission therefore comprises three distinct activities: Scientific research in micro- and nanotechnology, education of scientists and engineers in micro- and nanotechnology and transfer of scientific knowledge to industry. MIC has always been very active in seeking progressive and innovative ways for commercialization of research results. In the past decade MIC has generated 10 start-up and spin-off companies. Several of these companies have launched their first micro- and nanotechnology-based products. Commercialization of miniaturized technologies is a topic that is of great interest not only to MIC or Denmark but to many individuals and organisations in Scandinavia and I would like to build MANCEF's profile in our region. MANCEF can be of great help in the creation, exchange, and dissemination of knowledge vital to people, organizations, and governments interested in the commercialization of miniaturization technologies as stated in MANCEF's mission statement Professional Experience Pieter Telleman was born in 1965 in The Netherlands where he received a Chemical Engineering degree from the University of Twente (Enschede, The Netherlands) in 1987 and a M.Sc. degree in Biochemistry from the University of Nijmegen (Nijmegen, The Netherlands) in 1990. In 1995 he received his Ph.D. in Medicine from the University of Amsterdam (Amsterdam, The Netherlands). Following a fellowship award from the United States Army Medical Research Institute for Infectious Diseases (USAMRIID, Fort Detrick, MD, USA) he joined the Harvard Institutes of Medicine (Boston, MA, USA). He subsequently assumed fellowship positions in clinical oncology and experimental pathology at Harvard Medical School (Boston, MA, USA). Pieter Telleman was appointed professor in Bio/Chemical MicroSystems at the DTU in 2001 and assumed the position of the director of MIC-Department of Micro and Nanotechnology at the DTU in 2003.
© MANCEF - Micro And Nanotechnology
Commercialization Education Foundation |
